


Vertex Pharmaceuticals GCC Email Formats
Biotechnology Research • Technical and Scientific Services Office, Vertex Pharmaceuticals, Saudi Arabia • 1-10 Employees
Key Contact at Vertex Pharmaceuticals GCC
Samy Abdelsalam Abouelnaga
Pricing and Market Access Director
Company overview
| Headquarters | Technical and Scientific Services Office, Vertex Pharmaceuticals, Saudi Arabia |
| NAICS | 541714 |
| Keywords | Cystic Fibrosis, Sickle Cell Disease, Duchenne Muscular Dystrophy, Beta Thalassemia, Type 1 Diabetes Mellitus, Apol1-Mediated Kidney Disease, Alpha-1 Antitrypsin Deficiency (Aatd) |
| Founded | 1989 |
| Employees | 1-10 |
About Vertex Pharmaceuticals GCC
Vertex is a global biotechnology company with GCC headquarters in Riyadh, that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved therapies in multiple indications, and it continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it have deep insight into causal human biology, including neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1. Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 15 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex’s history of innovation, follow us on LinkedIn. Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Vertex Pharmaceuticals GCC has never raised funding before.
Frequently asked questions
4.8
40,000 users



